check_circleStudy Completed

Atrial Fibrillation

Bayer Identifier:

20398

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
OHDSI tools to characterize treatment pathways for stroke prevention in Atrial Fibrillation

Trial purpose

Key Participants Requirements

Sex

All

Age

18 - N/A
  • -

  • -

Trial summary

Enrollment Goal
386793
Trial Dates
January 2019 - August 2020
Phase
Phase 4
Could I Receive a placebo
N/A
Products
Unspecified
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
United Kingdom

Trial design

A study using OHDSI tools to characterize treatment pathways for stroke prevention in Atrial Fibrillation across diverse population settings TxPath-AF
Trial Type
Observational
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A